Dr. Stanley Yap on Sequential Therapy for Muscle-Invasive Bladder Cancer

Stanley Yap, MD
Published: Thursday, May 26, 2016



Stanley Yap, MD, assistant professor, urologic oncology, UC Davis Comprehensive Cancer Center, discusses sequential therapy after neoadjuvant chemotherapy for muscle-invasive bladder cancer.

The current standard of care for muscle-invasive bladder cancer is to give neoadjuvant chemotherapy followed by radical cystectomy. However, this is associated with a fair amount of morbidly, says Yap.

Yap and his team investigated the idea of sequential therapy to reduce unnecessary radical cystectomy. In his study, patients who had a pathological response following chemotherapy were offered surveillance, with radical cystectomy only after reoccurrence. This group of patients was followed for 10 years, explains Yap.

While some patient did extremely well, and never required a radical cystectomy, there was also a group of patients that faired poorly and did eventually receive a radical cystectomy. Because this study was inclusive, radical cystectomy should remain the standard of care for now, says Yap.
 


Stanley Yap, MD, assistant professor, urologic oncology, UC Davis Comprehensive Cancer Center, discusses sequential therapy after neoadjuvant chemotherapy for muscle-invasive bladder cancer.

The current standard of care for muscle-invasive bladder cancer is to give neoadjuvant chemotherapy followed by radical cystectomy. However, this is associated with a fair amount of morbidly, says Yap.

Yap and his team investigated the idea of sequential therapy to reduce unnecessary radical cystectomy. In his study, patients who had a pathological response following chemotherapy were offered surveillance, with radical cystectomy only after reoccurrence. This group of patients was followed for 10 years, explains Yap.

While some patient did extremely well, and never required a radical cystectomy, there was also a group of patients that faired poorly and did eventually receive a radical cystectomy. Because this study was inclusive, radical cystectomy should remain the standard of care for now, says Yap.
 

View Conference Coverage
Online CME Activities
TitleExpiration DateCME Credits
Medical Crossfire®: Key Questions for the Use of Immunotherapy Throughout the Disease Continuum for NSCLC in an Era of Rapid DevelopmentSep 29, 20181.5
Provider and Caregiver Connection™: Addressing Patient Concerns While Managing GlioblastomaSep 29, 20182.0
Publication Bottom Border
Border Publication
x